Evaluation of modified vaccinia virus Ankara expressing VP2 protein of infectious bursal disease virus as an immunogen in chickens
A recombinant modified vaccinia Ankara (MVA) virus expressing mature viral protein 2 (VP2) of the infectious bursal disease virus (IBDV) was constructed to develop MVA-based vaccines for poultry. We demonstrated that this recombinant virus was able to induce a specific immune response by observing t...
Main Authors: | Zanetti, Flavia Adriana, Zajac, María Paula Del Médico, Taboga, Oscar Alberto, Calamante, Gabriela |
---|---|
Format: | Online |
Language: | English |
Published: |
The Korean Society of Veterinary Science
2012
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386346/ |
Similar Items
-
Canarypox virus expressing infectious bursal disease VP2 protein as immunogen for chickens
by: Zanetti, Flavia Adriana, et al.
Published: (2014) -
Pathogenicity and immunogenicity of infectious bursal disease virus in poultry
by: Bejo, Mohd Hair, et al.
Published: (1999) -
Pathogenicity and Molecular Characterisation of the VP2 Gene of Infectious Bursal Disease Virus
by: Mahfuzul Hoque, Md
Published: (2001) -
Partial VP1 sequencing of Brazilian infectious bursal disease virus strains
by: Fernandes, Maria Judite Bittencourt, et al.
Published: (2012) -
The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host
by: Calvo-Pinilla, Eva, et al.
Published: (2018)